Showing results (311-320 of 427) with videos related to

Sort By:
Pageof 43
Breast Cancer Research and Treatment|May 24, 2018
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative studyDaneng Li, Linda M McCall, Olwen M Hahn, et al.
Journal of the National Cancer Institute|December 25, 2012
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutionsJonathan L Vandergrift, Joyce C Niland, Richard L Theriault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerChau Dang, Neil Iyengar, Farrah Datko, et al.
The AAPS Journal|June 17, 2017
Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance)Shailly Mehrotra, Manish R Sharma, Elizabeth Gray, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 8, 2020
Bridging the Gap Among Clinical Practice Guidelines for Pain Management in Cancer and Sickle Cell DiseaseAlyssa A Schatz, Thomas K Oliver, Robert A Swarm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancerA D Seidman, D Hochhauser, M Gollub, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 9, 2017
Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass IndexNeil M Iyengar, Kristy A Brown, Xi Kathy Zhou, et al.
Genes & Development|February 4, 2011
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancerKim J Png, Mitsukuni Yoshida, Xiang H-F Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2014
Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance)Lawrence N Shulman, Donald A Berry, Constance T Cirrincione, et al.
Breast Cancer Research and Treatment|March 17, 2006
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspectiveArti Hurria, Shari Goldfarb, Carol Rosen, et al.
Pageof 43